Catalent Inc., which partners with pharma, biotech and consumer health companies to optimize the development, launch and life-cycle supply of products for patients, will expand its existing operation and add a new R&D facility in Clark County, Kentucky. The $175 million project is expected to create 277 jobs.

The company's existing 190,000-square-foot Winchester facility will grow by 90,000 square feet to increase manufacturing capacity within Catalent’s oral dose division. The company also will acquire a nearly 17,000-square-foot building on Venable Road, which will house its R&D operations. Work on the project is expected to begin this year and to be completed by 2027. Catalent’ currently employs more than 650 people at the location.

“We look forward to further investing and growing in Winchester,” said Chris Rosenbaum, general manager of Catalent in Winchester. “The state of Kentucky’s talented workforce, tight-knit community and business environment provide major advantages to the future growth of Catalent.”

To encourage investment and job growth in the community, the Kentucky Economic Development Finance Authority (KEDFA) in April preliminarily approved incentive agreements with the company under the Kentucky Business Investment program. The performance-based agreement can provide tax incentives based on the company’s investment and annual job creation and wage targets. Additionally, KEDFA approved the company for tax incentives through the Kentucky Enterprise Initiative Act (KEIA). KEIA allows approved companies to recoup Kentucky sales and use tax on construction costs, building fixtures, equipment used in research and development and electronic processing.

By meeting its annual targets over the agreement term, the company can be eligible to keep a portion of the new tax revenue it generates. The company may claim eligible incentives against its income tax liability and/or wage assessments.

In addition, Catalent can receive resources from Kentucky’s workforce service providers. Those include no-cost recruitment and job placement services.

“It’s always great to see existing companies expand in Kentucky, but it’s even better when that growth includes great jobs for our residents,” Governor Andy Beshear said. “Catalent has been an important part of the Winchester community and the creation of 277 well-paying jobs will strengthen its presence in Clark County in the years to come. Thank you to Catalent’s leadership for continuing to create excellent job opportunities in our state.”

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. The company is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians.